Clinical Trial Update: Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of allogeneic mesenchymal stem cells for extensive chronic graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Graft Versus Host Disease | Phase 2 | Status: UNKNOWN